Capital Market Strategies LLC Increases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital Market Strategies LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,237 shares of the medical equipment provider’s stock after purchasing an additional 90 shares during the period. Capital Market Strategies LLC’s holdings in Intuitive Surgical were worth $646,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the company. Nordea Investment Management AB raised its holdings in shares of Intuitive Surgical by 31.7% in the fourth quarter. Nordea Investment Management AB now owns 43,200 shares of the medical equipment provider’s stock worth $22,632,000 after buying an additional 10,405 shares during the period. GAMMA Investing LLC increased its stake in Intuitive Surgical by 10.0% in the fourth quarter. GAMMA Investing LLC now owns 5,597 shares of the medical equipment provider’s stock worth $2,921,000 after purchasing an additional 507 shares during the period. Versant Capital Management Inc increased its stake in Intuitive Surgical by 27.4% in the fourth quarter. Versant Capital Management Inc now owns 688 shares of the medical equipment provider’s stock worth $359,000 after purchasing an additional 148 shares during the period. SMART Wealth LLC bought a new stake in shares of Intuitive Surgical during the third quarter worth $290,000. Finally, Exome Asset Management LLC grew its holdings in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. BTIG Research boosted their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Truist Financial upped their price target on shares of Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Robert W. Baird upped their price target on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Stock Performance

Shares of ISRG traded up $5.75 during trading hours on Monday, hitting $541.05. The stock had a trading volume of 425,061 shares, compared to its average volume of 856,272. Intuitive Surgical, Inc. has a fifty-two week low of $324.12 and a fifty-two week high of $556.23. The firm has a 50-day moving average price of $532.76 and a 200 day moving average price of $491.43. The firm has a market capitalization of $192.71 billion, a price-to-earnings ratio of 86.99, a PEG ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity

In related news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now owns 8,757 shares of the company’s stock, valued at $4,597,425. This trade represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock worth $25,012,927 over the last three months. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.